Processa Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Processa Pharmaceuticals, Inc. (PCSA) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 129.03 thousand shares as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2021-03-25
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 129.03K shares.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.28M shares.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.48M shares.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.67M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2020-12-31 | 129.03K shares 10-K · filed 2021-03-25 |
| 2017-09-30 | 1.28M shares 10-Q · filed 2017-11-20 |
| 2017-06-30 | 1.48M shares 10-Q · filed 2017-10-04 |
| 2017-03-31 | 1.67M shares 10-Q · filed 2017-10-04 |
| 2016-12-31 | 2.00M shares 10-Q · filed 2017-11-20 |
| 2016-09-30 | 2.00M shares 10-Q · filed 2017-09-08 |
| 2016-06-30 | 2.00M shares 10-Q · filed 2017-08-30 |
| 2016-03-31 | 2.00M shares 10-Q · filed 2017-08-07 |
| 2015-12-31 | 2.00M shares 10-K · filed 2017-09-25 |
| 2015-09-30 | 2.45M shares 10-Q · filed 2015-12-01 |
| 2015-06-30 | 2.45M shares 10-Q · filed 2015-08-19 |
| 2015-03-31 | 2.45M shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 2.42M shares 10-K · filed 2017-09-25 |
| 2014-09-30 | 1.17M shares 10-Q · filed 2014-11-13 |
| 2014-06-30 | 973.14K shares 10-Q · filed 2014-08-19 |
| 2014-03-31 | 723.82K shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | 363.82K shares 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |